VectivBio Holding AG
VECTNASDAQHealthcare
$16.87
+$0.02(+0.12%)
Market Cap$1.1B
P/E Ratio—
52W High$16.98
52W Low$4.25
VectivBio Holding AG（VECT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · VECT · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $27.34M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $27.34M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | 100.00% | — | — | — |
| Operating Expenses | ||||
| R&D Expenses | $73.95M | $50.18M | $43.03M | $15.98M |
| G&A Expenses | $33.91M | $35.81M | $14.02M | $8.23M |
| Total Operating Expenses | $107.86M | $86.72M | $57.26M | $24.32M |
| Operating Income | ($80.52M) | ($86.72M) | ($57.26M) | ($24.32M) |
| Operating Margin %(computed) | -294.52% | — | — | — |
| Interest Income | $0.68M | $0.00M | $0.00M | $0.01M |
| Interest Expense | $3.16M | $0.04M | $0.55M | $0.05M |
| Income Before Tax | ($93.63M) | ($86.94M) | ($59.94M) | ($23.48M) |
| Income Tax Expense | $0.11M | $0.06M | $0.55M | $0.05M |
| Net Income | ($93.73M) | ($87.01M) | ($60.50M) | ($23.53M) |
| Net Margin %(computed) | -342.84% | — | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-2.12 | $-3.23 | $-2.40 | $-1.01 |
| Wtd Avg Shares | 44.13M | 26.96M | 25.16M | 23.35M |
| EBITDA | ($79.85M) | ($86.41M) | ($57.55M) | ($23.26M) |
| EBITDA Margin %(computed) | -292.04% | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解VectivBio Holding AG
关于VectivBio Holding AG（VECT）损益表
VectivBio Holding AG（VECT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年，VECT实现营收$0.03B，毛利润$0.03B（毛利率100.00%），净利润($0.09B)（净利率-342.84%）。
常见问题
VECT · 4 问VectivBio Holding AG（VECT）2022财年营收为$0.03B，同比up—%。
VECT revenueVECT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09